Literature DB >> 11050061

Quantitative DNA fragment analysis for detecting low amounts of hepatitis B virus deletion mutants in highly viremic carriers.

F Schläger1, S Schaefer, M Metzler, N Gratzki, F Lampert, W H Gerlich, R Repp.   

Abstract

Many variants of hepatitis B virus (HBV) with deletions in the viral genome have been identified. Some of these variants are indicator or even effector of a more severe course of hepatitis. These deletion mutants contribute a variable and sometimes very low proportion to the viral population. For early detection of small amounts of deletion mutants among a large number of wild-type genomes, we applied a new screening method designated quantitative fragment analysis (QFA). By QFA the whole viral genome can be scanned for the presence of deletions or insertions of >/=3 nucleotides representing more than 2% of the viral population. Using QFA we showed that an often described deletion of 8 nucleotides is packaged in viral capsids and not a polymerase chain reaction (PCR) artifact. QFA was applied to study the emergence of deletion mutants in a group of 18 pediatric patients who had been infected from a common source while being under multidrug cancer chemotherapy. All patients had developed a highly viremic asymptomatic HBV carrier state. In 3 of these patients 3 different kinds of HBV deletion mutants were found by QFA: 8 bp deletions within the core promoter, core gene deletions from 8 to 86 bp, and large deletions of up to 1,989 bp spanning the precore/core and the preS/S reading frames. PCR primers that specifically amplify deletion variants enabled the detection of additional patients harboring the investigated variant.

Entities:  

Mesh:

Year:  2000        PMID: 11050061     DOI: 10.1053/jhep.2000.19323

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  3 in total

1.  In vivo transmission and dynamics of deleted genomes after experimental infection of woodchuck hepatitis B virus in adult animals.

Authors:  Valentina La Sorsa; Claudio Argentini; Roberto Bruni; Umberta Villano; Roberto Giuseppetti; Maria Rapicetta
Journal:  Virus Genes       Date:  2002-10       Impact factor: 2.332

2.  Genotype-dependent activation or repression of HBV enhancer II by transcription factor COUP-TF1.

Authors:  Silke F Fischer; Katja Schmidt; Nicola Fiedler; Dieter Glebe; Christian Schüttler; Jianguang Sun; Wolfram H Gerlich; Reinald Repp; Stephan Schaefer
Journal:  World J Gastroenterol       Date:  2006-10-07       Impact factor: 5.742

3.  HBx M130K and V131I (T-A) mutations in HBV genotype F during a follow-up study in chronic carriers.

Authors:  Bernal León; Lizeth Taylor; Minor Vargas; Ronald B Luftig; Federico Albertazzi; Libia Herrero; Kirsten Visona
Journal:  Virol J       Date:  2005-08-04       Impact factor: 4.099

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.